AstraZeneca’s Dapagliflozin has been approved by the Food and Drug Administration for its new indication for the treatment of Chronic Kidney Disease (CKD) in...
The Food and Drug Administration has approved Dapagliflozin to treat heart failure in adult patients with reduced ejection fraction.
Dapagliflozin, produced by UK-Swedish pharmaceutical firm...
AstraZeneca’s Dapagliflozin has been approved by the Philippine Food and Drug Administration for the prevention of new or worsening heart failure or cardiovascular death...
